Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Receivables: 2020-2025

Historic Receivables for Maravai Lifesciences Holdings (MRVI) over the last 5 years, with Sep 2025 value amounting to $22.5 million.

  • Maravai Lifesciences Holdings' Receivables fell 21.71% to $22.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $117.4 million, marking a year-over-year decrease of 24.15%. This contributed to the annual value of $38.5 million for FY2024, which is 29.46% down from last year.
  • Maravai Lifesciences Holdings' Receivables amounted to $22.5 million in Q3 2025, which was down 19.17% from $27.9 million recorded in Q2 2025.
  • Over the past 5 years, Maravai Lifesciences Holdings' Receivables peaked at $138.6 million during Q4 2022, and registered a low of $22.5 million during Q3 2025.
  • For the 3-year period, Maravai Lifesciences Holdings' Receivables averaged around $38.5 million, with its median value being $36.7 million (2024).
  • Per our database at Business Quant, Maravai Lifesciences Holdings' Receivables skyrocketed by 130.33% in 2021 and then plummeted by 60.61% in 2023.
  • Quarterly analysis of 5 years shows Maravai Lifesciences Holdings' Receivables stood at $117.5 million in 2021, then grew by 17.97% to $138.6 million in 2022, then crashed by 60.61% to $54.6 million in 2023, then decreased by 29.46% to $38.5 million in 2024, then dropped by 21.71% to $22.5 million in 2025.
  • Its Receivables was $22.5 million in Q3 2025, compared to $27.9 million in Q2 2025 and $28.5 million in Q1 2025.